Sophiris Bio is Drug Discovery in United States that focus on Sophiris Bio Inc business. Founded in 2002. They cover business area such as Sophiris Bio Inc, product, urological disease, topsalysin, low urinary tract symptom, benign prostatic hyperplasia, (BPH, localize low, intermediate risk prostate cancer, Topsalysin, enzymatically active prostate-specific antigen, (PSA, localized cell death, tissue disruption, damage, neighboring tissue, nerve.
2002
( 22 years old in 2024 )
Sophiris Bio Inc
-
1258 Prospect Street
San Diego, CA 92037
United States
Private
Sophiris Bio Incproducturological diseasetopsalysinlow urinary tract symptombenign prostatic hyperplasia(BPHlocalize lowintermediate risk prostate cancerTopsalysinenzymatically active prostate-specific antigen(PSAlocalized cell deathtissue disruptiondamageneighboring tissuenerve
* We use standard office opening hours in near Sophiris Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sophiris Bio is Drug Discovery business from United States that founded in 2002 (22 years old in 2024), Sophiris Bio business is focusing on Sophiris Bio Inc.
Sophiris Bio headquarter office and corporate office address is located in 1258 Prospect Street San Diego, CA 92037 United States.
Sophiris Bio was founded in United States.
In 2024, Sophiris Bio is currently focus on Sophiris Bio Inc sector.
Above is snippet of Google Trends for "Sophiris Bio Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sophiris Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
